UPDATE: Oppenheimer Starts Erickson Air-Crane (EAC) at Perform; Demand is Quite Seasonal
Tweet
Share
E-mailGet Alerts EAC Hot Sheet
Price: $10.65 --0%
Rating Summary:
4 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 11 | New: 17
Rating Summary:
4 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 11 | New: 17
Join SI Premium – FREE
(Updated - May 21, 2012 8:50 AM EDT)
Oppenheimer initiates coverage on Erickson Air-Crane (NASDAQ: EAC) with a Perform.
Analyst, Yair Reiner, said, "Erickson's attractive valuation, migration to longer term contracts, and potential FCF windfall from Aircrane sales, have the makings of an attractive investment. While soft free cash flow conversion keeps us sidelined for now, we'd revisit our stance upon progress on that front."
For an analyst ratings summary and ratings history on Erickson Air-Crane click here. For more ratings news on Erickson Air-Crane click here.
Shares of Erickson Air-Crane closed at $7.02 yesterday.
Oppenheimer initiates coverage on Erickson Air-Crane (NASDAQ: EAC) with a Perform.
Analyst, Yair Reiner, said, "Erickson's attractive valuation, migration to longer term contracts, and potential FCF windfall from Aircrane sales, have the makings of an attractive investment. While soft free cash flow conversion keeps us sidelined for now, we'd revisit our stance upon progress on that front."
For an analyst ratings summary and ratings history on Erickson Air-Crane click here. For more ratings news on Erickson Air-Crane click here.
Shares of Erickson Air-Crane closed at $7.02 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BMO Capital Resumes Global Net Lease (GNL), Upgrades to Outperform
- Jefferies Starts Aditya Birla Real Estate (ABREL:IN) at Buy
- Truist Securities Reinstates Pacira Pharmaceuticals (PCRX) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
